These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia. Looper KJ; Chouinard G Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698 [No Abstract] [Full Text] [Related]
5. Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa syndrome). Suzuki T; Hori T; Baba A; Abe S; Shiraishi H; Moroji T; Piletz JE J Clin Psychopharmacol; 1999 Jun; 19(3):277-80. PubMed ID: 10350039 [No Abstract] [Full Text] [Related]
12. Dose-Dependent Effects of Lithium Treatment on the Aggravation of Antipsychotic-Induced Pisa Syndrome. Hsieh HT; Yeh YW Clin Neuropharmacol; 2020; 43(3):90-91. PubMed ID: 32384312 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of the Pisa syndrome. Suzuki T; Koizumi J; Moroji T; Sakuma K; Hori M; Hori T Acta Psychiatr Scand; 1990 Dec; 82(6):454-7. PubMed ID: 1981297 [TBL] [Abstract][Full Text] [Related]
14. Treatment of persistent myoclonic tardive dystonia with verapamil. Abad V; Ovsiew F Br J Psychiatry; 1993 Apr; 162():554-6. PubMed ID: 8097657 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic induced tardive dyskinesia in a patient on treatment for schizophrenia: case report. Atwoli L; Manguro G; Owiti P; Ndambuki D East Afr Med J; 2009 Jul; 86(7):354-6. PubMed ID: 20499786 [TBL] [Abstract][Full Text] [Related]